StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
IXICO plc
LSE:IXI.L
Sector
Location
Market Cap
USD 13.37 M
Share Price
USD 0.14
Avg Daily Volume
67,240
Change (1 day)
0.13%
Change (1 year)
59.71%
Change (YTD)
-1.82%
IXICO plc Enterprise Value to EBITDA (EV/EBITDA) on July 21, 2025
IXICO plc Enterprise Value to EBITDA (EV/EBITDA) is NA on July 21, 2025. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
-
IXICO plc 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -4.11 on July 21, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
-
IXICO plc 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -12.00 on July 21, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
-
IXICO plc average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is -8.03.
Competitors
Natera, Inc.
USD 140.63
NTRA
+1.73
1.25%
Veracyte, Inc.
USD 23.03
VCYT
-0.48
-2.04%
Boston Scientific Corporation
USD 103.78
BSX
+0.14
0.14%
RELX Plc
USD 52.89
REL.L
-0.15
-0.29%
Siemens Healthineers AG
USD 53.54
SHL.DE
-0.07
-0.12%
Cencora, Inc.
USD 292.67
COR
-0.20
-0.07%
Edwards Lifesciences Corporation
USD 76.56
EW
+0.07
0.09%
GE HealthCare Technologies Inc.
USD 74.16
GEHC
-1.80
-2.37%
DexCom, Inc.
USD 84.03
DXCM
+0.14
0.17%
IQVIA Holdings Inc.
USD 158.96
IQV
-1.67
-1.04%
Laboratory Corporation of America Holdings
USD 243.04
LH
-0.68
-0.28%
Somnigroup International Inc
USD 73.84
SGI
+0.52
0.71%
Illumina, Inc.
USD 94.80
ILMN
-1.34
-1.40%
Hologic, Inc.
USD 63.69
HOLX
-0.30
-0.47%
Baxter International Inc.
USD 27.37
BAX
-0.40
-1.44%
Torrent Pharmaceuticals Limited
USD 40.49
TORNTPHARM.NS
-0.35
-0.85%
Fisher & Paykel Healthcare Corporation Limited
USD 21.91
FPH.NZ
-0.22
-0.98%
Zydus Lifesciences Limited
USD 11.13
ZYDUSLIFE.NS
-0.11
-0.97%
ICON Public Limited Company
USD 139.63
ICLR
-3.91
-2.72%
Tempus AI, Inc.
USD 58.01
TEM
-2.97
-4.87%
Key Data
| Date | Enterprise Value to EBITDA (EV/EBITDA) | Free Cash Flow Yield | Dividend Yield | Market Capitalization |
|---|
Competitors
Natera, Inc.
USD 140.63
NTRA
+1.73
1.25%
Veracyte, Inc.
USD 23.03
VCYT
-0.48
-2.04%
Boston Scientific Corporation
USD 103.78
BSX
+0.14
0.14%
RELX Plc
USD 52.89
REL.L
-0.15
-0.29%
Siemens Healthineers AG
USD 53.54
SHL.DE
-0.07
-0.12%
Cencora, Inc.
USD 292.67
COR
-0.20
-0.07%
Edwards Lifesciences Corporation
USD 76.56
EW
+0.07
0.09%
GE HealthCare Technologies Inc.
USD 74.16
GEHC
-1.80
-2.37%
DexCom, Inc.
USD 84.03
DXCM
+0.14
0.17%
IQVIA Holdings Inc.
USD 158.96
IQV
-1.67
-1.04%
Laboratory Corporation of America Holdings
USD 243.04
LH
-0.68
-0.28%
Somnigroup International Inc
USD 73.84
SGI
+0.52
0.71%
Illumina, Inc.
USD 94.80
ILMN
-1.34
-1.40%
Hologic, Inc.
USD 63.69
HOLX
-0.30
-0.47%
Baxter International Inc.
USD 27.37
BAX
-0.40
-1.44%
Torrent Pharmaceuticals Limited
USD 40.49
TORNTPHARM.NS
-0.35
-0.85%
Fisher & Paykel Healthcare Corporation Limited
USD 21.91
FPH.NZ
-0.22
-0.98%
Zydus Lifesciences Limited
USD 11.13
ZYDUSLIFE.NS
-0.11
-0.97%
ICON Public Limited Company
USD 139.63
ICLR
-3.91
-2.72%
Tempus AI, Inc.
USD 58.01
TEM
-2.97
-4.87%